Economic evaluations of lymphatic filariasis interventions: a systematic review and research needs

Parasites & Vectors

Table 4 Summary of the average treatment costs of the GPELF (2000–2014)

Cost type	Average cost per treatment (95% CI)
Financial costs	US$ 0.46 (0.21–0.76)
Economic costs - excluding the donated drugs value	US$ 0.56 (0.25–0.94)
Economic costs - including the donated drugs value	US$ 1.32 (1.00–1.69)

Notes: The shown costs represent an overall average of the GPELF (2000–2014) adapted from Turner et al. [17]. The delivery costs were estimated using the web-based regression MDA costing model developed by the WHO [53]. It should be noted that model parametrisation relating to the use of paid health workers and not community volunteers for the drug distribution was used (resulting in a higher unit delivery cost). Further details are provided in Turner et al. [17]. Prices were adjusted to 2014 US$ [19]

ISSN: 1756-3305